Skip to content

To evaluate the safety and performance of the Bovine Pericardial Tissue Patch

A PMCF study to evaluate the safety and efficacy of the Bovine Pericardial Tissue Patch - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071956
Enrollment
15
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

Intervention1: Bovine Pericardial Tissue Patch: Tisgenx’s BPT Patch is intended for use as a surgical patch for cardiac and vascular reconstruction and repair, soft tissue deficiency repair, and rei

Sponsors

Tisgenx, Inc.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing cardiac surgery requiring a patch for intracardiac or extracardiac repair.

Exclusion criteria

Exclusion criteria: Patients with known allergies to bovine products or pre-existing conditions contraindicating the use of bovine pericardial patches.

Design outcomes

Primary

MeasureTime frame
1. To assess the patch performance in terms of preoperative imaging, surgical handling, postoperative outcomes and follow-up echocardiography 2. To study the safety in terms of Patch-related complication and Intra & postoperative complications Timepoint: Postoperatively: 1. 1 month 2. 3rd month 3. 6th month 4. Last Follow-up 1 year

Secondary

MeasureTime frame
To study the effectiveness of the Bovine Pericardial Tissue Patch Handling characteristics, Patient outcome: ICU days, Hospital days, follow-up echo for cardiac surgery patients to look for patch integrity & Mortality & reoperation ratesTimepoint: Postoperatively: 1. 1 month 2. 3rd month 3. 6th month 4. Last Follow-up 1 year

Countries

India

Contacts

Public ContactDr Vishal V Bhende

Bhanubhai and Madhuben Patel Cardiac Centre

drvishalbhende@gmail.com07708997222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026